rss
Br J Sports Med 2006;40:627-631 doi:10.1136/bjsm.2006.026237
  • Original article

Short term salbutamol ingestion and supramaximal exercise in healthy women

  1. B Le Panse1,
  2. A Arlettaz1,
  3. H Portier1,
  4. A-M Lecoq2,
  5. J De Ceaurriz3,
  6. K Collomp4
  1. 1Laboratoire Activité Physique, Santé et Performance (LAPSEP), University of Orléans, Orléans, France
  2. 2Service de Physiopathologie de l’exercice, Laboratoire Activité Physique, Santé et Performance, Orléans
  3. 3Laboratoire National de Depistage du Dopage (LNDD), Chatenay-Malabry, France
  4. 4Laboratoire Activité Physique, Santé et Performance, Laboratoire National de Depistage du Dopage
  1. Correspondence to:
 Professor Collomp
 Laboratoire Activité Physique, Santé et Performance, Faculté du Sport et de l’Education Physique, 2, Allée du Chateau, BP 6237, 45062 Orléans Cedex 2, France; katia.collomp{at}univ-orleans.fr
  • Accepted 23 April 2006
  • Published Online First 10 May 2006

Abstract

Objective: To test the hypothesis that chronic salbutamol intake improves performance during supramaximal exercise and to estimate the effects of this treatment on body composition, bone mass, and metabolic indices in healthy women.

Methods: Fourteen female volunteers (seven sedentary and seven recreationally trained) performed a 30 second Wingate test with and without salbutamol ingestion (12 mg/day for four weeks) in a random, double blind, crossover design. Blood samples were collected at rest, at the end of the test, and during passive recovery for lactate measurement. Body composition and bone mass were determined by dual energy x ray absorptiometry.

Results: Peak power appeared significantly earlier and was significantly (p<0.05) increased after salbutamol intake in all subjects. There was no difference in total work performed and fatigue indices with salbutamol compared with placebo. No significant alterations in lean or fat body mass and bone variables were observed with salbutamol treatment in either trained or untrained subjects during the trial. In contrast, blood lactate was significantly (p<0.05) increased during the recovery period after salbutamol ingestion compared with placebo.

Conclusion: As in men, chronic administration of therapeutic concentrations of salbutamol did not induce an anabolic effect in women but increased maximal anaerobic power. Further studies are necessary to clarify the mechanisms involved.

Footnotes

  • Published Online First 10 May 2006

  • Competing interests: none declared

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjsm.2006.026237v1
    2. 40/7/627 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.